Methylphenidate in Early Poststroke Recovery

Completed

Phase 2 Results

Results

Patients receiving methylphenidate treatment scored lower on the HAM-D (p=.028), lower on the ZDS (p=.055), higher on the M-FIM (p=.032), and higher on the FMS (p=.075) than patients receiving placebo.